BeOne Medicines Ltd.
(ONC - NASDAQ)
310,75 USD
📋 Profilo Aziendale

BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies.

|